Quantum Media Group, LLC

Driving Innovation in Telecoms: An Interview with David Zoldan, CEO of Launch 3 Telecom - TechBullion

Q&A with Matt Edelman, CEO at Super League | citybiz

Modern Fashion: Aaron Tuchman Of Noble Custom Suits On 5 Things You Need To Lead a Successful Fashion Brand Today | by Authority Magazine Editorial Staff | Authority Magazine | Jan, 2026 | Medium

Peter Goldstein Of Exchange Listing LLC: Five Things I Wish Someone Told Me Before I Became A CEO | by Authority Magazine Editorial Staff | Authority Magazine | Sep, 2025 | Medium

Bitcoin IRA: Helping Americans Retire with Crypto | NYSE Interview with Chris Kline

The summer slide is real. The 30-minute-a-week math hack parents are raving about

AI Biologics: The Overlooked Frontier of Drug Discovery? | Investing.com

Mark Madrid: Fueling Small Business Excellence Through AI, Access & Action | NYSE Interview

Biotech Breakout? How a 2-Week Depression Pill Could Trigger a Market Repricing

The Future is Faster Than You Think: Dr Yun K Tam of SinoVeda

Zedge: Making Phones Personal

Scrip Asks... What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances

The Future of Anxiety Relief

Major Shareholder Doubles Down: Pluri Lands $3.5M Premium Investment as Growth Plans Accelerate

Q&A with Yaky Yanay, President and CEO, Pluri | citybiz

A Transformative Shift in Cancer Care: How One Partnership Is Bringing AI to Healthcare

Scrip Asks... What Does 2025 Hold For Biopharma? Part 4: Artificial Intelligence and Data Science

Here Are Four Small-Cap Stocks in Honor of World Cancer Day

Israel's Pluri secures $6.5M strategic Investment, Enters Cacao market - AgroSpectrum Asia

Pluri Secures $6.5M Investment, Acquires Cacao Company

Lab-Grown Chocolate: Israel's Pluri Acquires Kokomodo, Raises $6.5M

Yaky Yanay: Revolutionizing Biotech with Pluri's Cell-Based Solutions

Pluri CEO & President Yaky Yanay

These Biotechs are Using the Same Treatments for Multiple Neurodegenerative Diseases: Here's Why it Works

Biotechs are Accelerating Drug Discovery by Repurposing Platforms: What This Means for Investors

Artificial Intelligence Makes Possible a Multiomic Approach in Oncology Drug Discovery

Unlocking AI investment opportunities in healthcare

Inhibikase Therapeutics: Targeted Therapies That Can Improve Quality Of Life | Investing.com

Next-gen farming | The Cell Base

Sustainability innovations that made headlines in 2024 - Natura Hoy

How Creative Marketers Use Artificial Intelligence to Deliver a Better Experience

Tech Is Shaping the Future of Food: Here's How Venture Capital is Carrying that Tech Across the Finish Line

Best-Performing Small-Cap Stocks of 2024 | Investing.com

3 Must-Have Cars For the Traveling Entrepreneur

Under-the-Radar Way to Invest in AI: 6 Health-Care Stocks for Exposure to Artificial Intelligence

Unlocking AI investment opportunities in healthcare

These 3 Things Are Going to Change the Business Landscape Forever

Four Things Every Investor Relations Officer Needs to Know About AI

With climate change threatening commodity foods, these technologies are coming to the rescue

New Technology Addresses At-Risk Commodity Ingredients - Food Industry Executive

IPA's Innovative Approach to Antibody Discovery and AI Integration - Top Entrepreneurs Podcast | Enterprise Podcast Network

Malta or Portugal: Navigating Investment Migration Options

C-Suite Perspectives On AI: Dr Jennifer Bath Of ImmunoPrecise Antibodies On Where to Use AI and

Climate Change Is Coming for these Food Staples, So Technology is Taking Farming into the Lab

Commodity Markets at Risk for Destabilization as Tech Takes Farming Into the Lab | Investing.com

Improving Cell Therapy Supply Chains

FORMULATION DEVELOPMENT - Practical & Purposeful: Creating Novel Compounds Via Rediscovery R&D & Cannabinoid Molecules

Simplifying Diabetes with an Implantable CGM – Paul V. Goode, PhD, Glucotrack CEO

New frontier for battery metals: Q&A with Craig Shesky, CFO of The Metals Company By Investing.com

Don't write off cultivated meat just yet, says Ever After Foods: ‘We’re not offering incremental improvements but something truly disruptive’

FORMULATION DEVELOPMENT - Practical & Purposeful: Creating Novel Compounds Via Rediscovery R&D & Cannabinoid Molecules

No matter who wins the election, experts expect 'a significant number' of rich Americans to flee the country

Greening Your Investments: How to Protect Your Portfolio Against Climate Threats | Investing.com

Jon Green Of Latitude On the Future Of Work

Advancing Cell Therapies in Development Through CDMOs

Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology - Pharmaceutical Technology

Pluri launches manufacturing division as cell therapy pipeline progresses - Pharmaceutical Technology

Harnessing the Power of Data Analytics in Investor Relations

Shaping the Future of Longevity With Yaky Yanay And James “Jim” Roosevelt from Pluri : How Pluri’s Therapies Are Shaping the Future of Aging and Healthcare

Pluri launches manufacturing division as cell therapy pipeline progresses - Pharmaceutical Technology

Frontiers of Healing: Joel Latham’s Quest to Transform Modern Medicine

How AI Technology Is Revolutionizing Early Breast Cancer Detection and Treatment

Leading the Biotherapeutics Revolution: Interview with Dr. Jennifer Bath, CEO of ImmunoPrecise Antibodies

AgTech: Michal Ogolnik On The New Technologies That Are Revolutionizing Agriculture

Regenerative Medicine is the Future of Healthcare | Pluri CEO, Yaky Yanay, Co-hosted with Juvenescence Chairman, Dr. Greg Bailey

Jon Green Podcast Transcript

Climate change is actually draining our bank accounts. Here's what to do

Future of Metal Production: Craig Shesky and The Metals Company’s Mission

Joel Latham, Incannex Healthcare, on a Promising New Combination Therapy for Obstructive Sleep Apnea

3D Cell-Expansion Technology Revolutionizing Industries: Interview with Lior Raviv, Chief Technology Officer at Pluri

These Four Biotech Stocks Tap into the Impact-Investing Movement

Ever wondered how deep-sea nodules power EVs? 🌊🔋

Innovative Strides in Sleep Apnea Treatment: Incannex’s IHL-42X Enters Pivotal Phase 2/3 Trials.

Passport to prosperity: Why high-net-worth individuals need dual citizenship

4 Psychedelic Stocks to Consider as Clinical Trials Heat up | Investing.com

Off the Shelf Platform: Efrat Kaduri from Pluri Inc. In a Riveting Conversation with PharmaShots

Latitude’s Chris Willis Talks About Real Estate and What to Know About Foreign Citizenship and Residency by Investment

IPA Therapeutics: A HUB of Biotherapeutic Intelligence

Ascent Solar: Solar power solution for scenarios where traditional rigid panels won't work

3 under-the-radar ways the Inflation Reduction Act has made significant impact (including to your wallet)

Securing Your Future through Investment Migration - Interview with Managing Partner: Jon Green

How to overcome the challenges of mechanical contactors for efficient EV charging

Driving Efficiency and Affordability in Energy with Ideal Power CEO, Dan Brdar

Driving Disruption: Joel Latham Of Incannex Healthcare On The Innovative Approaches They Are Taking…

CDMO Specialization

USA: Jennifer Bath on IPA's AI-Driven Drug Discovery, Solving Data Overload in Pharmaceuticals

Unsung Heroes in the Fight Against Climate Change: 5 Small Caps for Climate Week | investing.com

How NVIDIA Stock Became a Wall Street Darling After Years Under the Radar | Investing.com

How Cannabinoid Biotechs Are Potentially Enhancing Long-Term Stock Performance | Investing.com

Pluri bags $1.4m to advance nuclear radiation therapy

EXCLUSIVE: Seabed Mining Company Execs See Industry Developing Regardless Of UN Authority Vote - TMC Metals (NASDAQ:TMC)

Stirring the pot: Bioreactor breakthroughs | The Cell Base

USA: Pluri's Tech Revolution: Mass Cell Production & Future Solutions

Vehicles of The Future: Jeff Knapp Of Ideal Power On The Leading Edge Technologies That Are Making…

Pluri: Transforming cells into solutions

Is CPAP Technology Becoming Obsolete? New Treatments Offer Hope in Sleep Apnea

The Future of Cell-Based Products with Yaky Yanay, CEO of Pluri

The Technology Behind The Technology: How Ideal Power is Driving EVs Forward - Top Entrepreneurs Podcast | Enterprise Podcast Network

69% of OSA Patients Willing to Switch to Pill Treatment, Finds Quantum Research-Incannex Survey

Ever After Foods receives $10 million investment

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Why Millennials Still Respond to This Old-School Marketing Tactic

More Drug Does Not Always Lead to More Efficacy: Dr Mark Bleackley on the Progress of the RePOSA Study